The eSafety Commissioner has told the Full Court X Corp should not be able to use its merger with corporate predecessor Twitter to escape regulation.
Mid-trial amendments to a class action over Victoria Police use of pepper spray on environmental protesters in 2019 claim officers deployed the spray knowing and intending that it would harm the activists.
Former Spotlight producer Taylor Auerbach has sued Seven over comments it made concerning his dealings with Bruce Lehrmann, after he gave “sordid” evidence in the defamation trial.
A lawyer accused of trying to blackmail personal injury firm Maliganis Edwards Johnson has won a challenge to an injunction, with a judge finding the blackmail allegation was more nuanced than conveyed by the Canberra firm.
US lab products giant Beckman Coulter has successfully opposed an Australian biotech’s bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman’s ‘CytoFLEX’ mark.
Payday lender Sunshine Loans has lost an appeal after it was ruled liable for “wrongheaded” conduct, with an appeals court finding that counsel showed an “egregious failure” to confine the case to the real issues.
The funder that backed a shareholder class action against engineering firm CIMIC that settled for $45.25 million will take a cut to its 25 per cent commission, but wants the court to find the commission would otherwise have been reasonable.
United Petroleum has successfully sued the landlords of one of its petrol stations for failing to pay for repairs to potholes described as “more like large craters”.
Another fight over an $87 million mixed-use Canberra development may be on the cards, after the project’s liquidators won approval to assign potential claims against WSP and builder Construction Control over alleged stitch bolt defects.
Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.